本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Redhill Biopharma Ltd

2.02
-0.1500-6.91%
盘后2.100.0800+3.96%19:45 EDT
成交量:33.95万
成交额:71.14万
市值:463.66万
市盈率:-0.30
高:2.27
开:2.23
低:1.95
收:2.17
数据加载中...
2019/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/29

非美公司披露报告

2018/10/25

非美公司披露报告

2018/10/24

非美公司披露报告